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Abstract
The way that public involvement in research has been evaluated as a complex intervention has derailed the development
of an evidence base. Two alternative approaches are available for constructing and evaluating patient involvement, each of
which requires us to revisit the purposes and values that underpin it in each stage of the research process.
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Background
Public involvement (PI) in research has been deﬁned as
‘research being carried out with or by members of the
public rather than to, about or for them as mere
research participants’.1 PI in research often refers to
consultation or collaboration with lay people on activ-
ities such as choosing which outcomes to measure,
designing recruitment materials and presenting
ﬁndings.
Increasingly, PI is mandated by many institutions
involved in health and social care research, dovetailing
with movements towards PI in health care and the
patient as consumer.2 Research funders in the UK com-
monly require applicants to detail how PI has, and will
continue to, inform their proposed research.3,4
Difficulties in evaluating the benefits
of public involvement
Considerable guidance is available5–7 on how to under-
take PI, largely based on grey literature and qualitative
research. This has identiﬁed important issues around
tokenism and the well-being of lay people in research
environments.8 More problematic has been the devel-
opment of an evidence base of the impact of PI on
research, fuelled by rhetoric such as:‘ . . . active involve-
ment of the public in the research process leads to
research that is more relevant to people and is more
likely to be used’.9
Such statements present a consequentialist rationale
for PI,10 one in which PI is endorsed as morally right
based on its beneﬁcial consequences in improving the
quality and relevance of research. This rationale has
been presented as instrumental,11 pragmatic,12 and the
methodological argument.2,13,14
Reviews of empirical work do suggest PI can
improve the quality, relevance and ethical conduct of
research.6,15–17 Nonetheless, the quest for evidence of
such beneﬁt has been diﬃcult, prompting suggestions
that academics have failed in this regard.18
We propose four key reasons for these diﬃculties.
Firstly, the entire consequentialist rationale for PI in
research is contested by those proposing a deonto-
logical rationale (i.e. giving rightful voice and power
to those at the heart of health care). This rationale
has been termed ideological,12 moralistic19 and the
moral and ethical perspective,2,13 its position summed
up as: ‘deﬁning consumer involvement outcomes solely
in terms of research quality ignores the rights of those
being researched or likely to beneﬁt from the
research’.13
Secondly, there is contention about what types of
impact such as improved study recruitment rates are
worth investigating for whom, when and why.20
Similarly, disagreement persists about which indicators
and methods can and should be used, with concerns
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about weak study designs.21 But most importantly,
underpinning these disagreements is a trend towards
evaluating PI in the same manner as one would evalu-
ate therapeutic interventions such as surgical proced-
ures, drugs or screening programmes.
Evaluating public involvement as if it
were a therapeutic intervention
Much clinical and health services research concerns the
evaluation of therapeutic interventions and employs a
variety of research methods and processes to do so. PI
is a component of the research process, i.e. the activities
of research funding, design, conduct, analysis and dis-
semination. Yet instead of evaluating PI as part of the
research process it is commonly evaluated as if it were
itself a therapeutic intervention. This approach, which
tends towards deﬁning and evaluating PI as a complex
intervention22,23 or complex social intervention,7 is the
reason why evaluation has proved diﬃcult.
Complex interventions comprise two or more active
components (e.g. medication plus adherence counsel-
ling). Their evaluation often includes process evalu-
ation, comparison of outcomes between those
receiving and not receiving the intervention, and realist
evaluation. The latter emphasizes the context of deliv-
ery and has been recommended and used for PI in
studies in the UK funded by the National Institute of
Health Research with INVOLVE13,24 and the Medical
Research Council.25–27
This trend has arisen because of the complexity and
importance of context regarding PI in research.13
However, this has also created a misconstruction of
PI in research, using unsuitable methods such as realist
evaluation.24 This has derailed the development of a
meaningful and robust evidence base. In place of eval-
uating (and hence implicitly constructing) PI as if it
were a therapeutic intervention, alternative construc-
tions of PI are needed from which approaches to evalu-
ation will then follow.
Alternative constructions of public
involvement in research
If we reject the construction of PI as an intervention
and recognize it as part of the research process, what
alternative constructions exist? From a deontological
perspective we might construct PI as a contribution of
expertise and advocacy, equitable to the contribution of
clinicians, statisticians or others. Therefore, we might
focus evaluation on the processes by which: the pur-
poses of PI in a given scenario can be made explicit;
lay knowledge can be brought forth and integrated with
other expert knowledge; and advocacy and
accountability for and by all parties can best be
achieved. (The notion of advocacy also lies at the
heart of controversy about training lay people in
research methods,28 in which the implicit concern is
whether one can advocate for lay people having
adopted the interests of the researcher through
training.)
Alternatively, we might adopt a consequentialist
rationale, constructing PI in research as a methodo-
logical activity to improve research quality and drawing
inspiration from evaluation of research methods. Such
evaluation usually comprises critique of their congru-
ence with stated purpose and theory. Crucially,
research methods are not tested against pre-determined
outcomes in the manner that we would evaluate a com-
plex intervention, and in which PI is commonly
evaluated.
Conclusions
Theorization of PI has tended towards an internal
focus,29 categorizing levels of power and responsibility.
However, we also need to theorize the nature and pur-
poses of PI in relation to the overarching aims and
processes of health research. Diﬀerent purposes and
constructions of PI may suit diﬀerent stages of the
research process. For example, the purpose of lay rep-
resentation on a generic research funding panel may be
public accountability – best served by a deontological
construction of PI as public advocacy. In contrast,
the purpose of lay involvement in study design may
be to improve the quality of the research regarding
such aspects as recruitment, attrition and patient-
centred outcomes. This may be best served by a conse-
quentialist construction of PI as a methodological
activity.
PI in research cannot – and should not – be eval-
uated as an intervention but rather as part of the
research process. Alternative constructions of PI,
that acknowledge this, are possible. Chiming with
recent calls for the development of common goals
for PI in research,18,29 we must revisit its values and
purposes. This would provide the foundations for
identifying constructions that allow meaningful evalu-
ation of those intentions and by appropriate means.
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